Patent details

Basic Information

Publication number:

EP1729729

PCT Application Number:

PCT/EP/2005/003062

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP057163073

PCT Publication Number:

WO/2005/089718

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

22/03/2005

Grant date:

23/04/2014

EP Publication Date:

23/04/2014

PCT Publication Date:

29/09/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/12/2006

EP B1 Publication Date:

23/04/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/03/2015

Expiration date:

22/03/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/03/2005

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

SCHNEEBERGER Ricardo

Address:

France (FR)

2

Name:

MUHRER Gerhard

Address:

Switzerland (CH)

3

Name:

BAUMBERGER Anton

Address:

Switzerland (CH)

4

Name:

WIRTH Wolfgang

Address:

Switzerland (CH)

Priority

1

Priority Number:

0406515

Priority Date:

23/03/2004

Priority Country:

United Kingdom (GB)

2

Priority Number:

0424727

Priority Date:

09/11/2004

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 9/14;

Filing date	Document type	Number of pages